Avicanna Inc.
TSX: AVCN.TO0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Toronto Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Aras Azadian Mba
- Employees
- 87
- Headquarters
- Toronto, Canada
- IPO year
- 2019
- Market cap
- CA$17.0M
- Website
- https://www.avicanna.com
Loading AVCN…
Loading profile data…Frequently asked questions about AVCN
What does Avicanna Inc. (AVCN.TO) do?
Avicanna Inc., a commercial-stage biopharmaceutical company, engages in the research and development of evidence-based products for consumer medical and pharmaceutical segments worldwide. The company collaborates with Canadian academic and medical institutions. Its scientific platform includes research and development, and clinical development t...
Where does AVCN.TO trade?
Avicanna Inc. (AVCN.TO) trades on the Toronto Stock Exchange.
What sector is AVCN.TO in?
Avicanna Inc. (AVCN.TO) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Avicanna Inc.?
Aras Azadian Mba is the chief executive officer of Avicanna Inc. (AVCN.TO).
Where is Avicanna Inc. headquartered?
Avicanna Inc. is headquartered in Canada.
Does AVCN.TO pay a dividend?
Avicanna Inc. (AVCN.TO) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did AVCN.TO go public?
Avicanna Inc. (AVCN.TO) completed its initial public offering in 2019.